• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, October 25, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Terasaki Institute for Biomedical Innovation and Openwater Form collaboration

Bioengineer by Bioengineer
July 6, 2022
in Health
Reading Time: 2 mins read
0
Terasaki Institute for Biomedical Innovation and Openwater Form Collaboration
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

(LOS ANGELES) – The Terasaki Institute for Biomedical Innovation (TIBI) has formally signed a collaborative agreement with San Francisco-based Openwater. TIBI, founded in 2020, fosters personalized medicine with their scientific research platforms for physiological models, devices, implants, cells, biomaterials and nutrition. They also incorporate business and technology transfer experts to adapt and develop their innovations for real-world use in the clinic.

Terasaki Institute for Biomedical Innovation and Openwater Form Collaboration

Credit: Terasaki Institute for Biomedical Innovation

(LOS ANGELES) – The Terasaki Institute for Biomedical Innovation (TIBI) has formally signed a collaborative agreement with San Francisco-based Openwater. TIBI, founded in 2020, fosters personalized medicine with their scientific research platforms for physiological models, devices, implants, cells, biomaterials and nutrition. They also incorporate business and technology transfer experts to adapt and develop their innovations for real-world use in the clinic.

Openwater, founded in 2016, is a company whose extensive resources are used to produce revolutionary medical imaging technologies. In addition to using these technologies for a variety of high-impact diagnostic applications, Openwater’s ultrasonic systems have the potential to be used for therapeutic purposes, such as in treatments for injuries or diseases of the brain.

Said Mary Lou Jepsen, Ph.D., founder and CEO of Openwater, “Openwater is a game-changing company focused on the future of neurodiagnostics and brain therapeutics. The team consists of seasoned entrepreneurs and a dedicated group of experts with storied careers and deep expertise in advanced physics, optics, lasers, ultrasonics, physics, electronics, medical devices, software, and manufacturing. Breakthrough novel lasers, opto-electronic and holographic systems enable Openwater’s neurodiagnostic and brain therapeutic systems to advance the state of brain imaging and treatments. Delivering life-saving technologies is at the core of what Openwater aims to achieve.”

Before these therapeutic applications can be implemented in the clinic, however, they should be thoroughly studied and validated in the laboratory, ideally using in vitro tissue models that closely mimic human tissue systems in the body.

Openwater’s collaborative effort with TIBI will leverage TIBI’s long-standing expertise in 3D tissue engineering and architecture to design and construct such a model. The TIBI researchers will build the model in phases, while optimizing it and performing functional tests at each phase. They will then use the model to test the performance of one of Openwater’s therapeutic devices.

The success of the project will help to improve therapeutic screening efficacy and may lead to the development of other therapeutic applications. TIBI’s tissue model can also be used in developing personalized medical treatments and can be incorporated into high-throughput platforms for drug screening and development of novel therapies.

“Using accurate physiological models is a key component in the successful development of impactful therapies for the clinic,” said Ali Khademhosseini, Ph.D., TIBI’s Director and CEO. “We look forward to using our expertise in this area to maximize our collaborative efforts with Openwater.” 



Share12Tweet8Share2ShareShareShare2

Related Posts

Innovative Study to Reduce Home Treatment for Dementia

October 25, 2025

Evaluating Integrated Safety Management Systems: A Study

October 25, 2025

Evaluating the Impact and Value of Automated External Defibrillators in Residential Settings

October 25, 2025

Unraveling Sleep Issues in Rare Genetic Disorders

October 25, 2025

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1281 shares
    Share 512 Tweet 320
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    309 shares
    Share 124 Tweet 77
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    190 shares
    Share 76 Tweet 48
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    133 shares
    Share 53 Tweet 33

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Innovative Study to Reduce Home Treatment for Dementia

Evaluating Integrated Safety Management Systems: A Study

Avocado Seed Meal Boosts Quail Growth and Meat Quality

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 66 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.